Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001086228 | SCV000754732 | benign | Adrenoleukodystrophy | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000633497 | SCV001150488 | uncertain significance | not provided | 2017-06-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001086228 | SCV002045775 | likely benign | Adrenoleukodystrophy | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002413815 | SCV002721990 | benign | Inborn genetic diseases | 2017-08-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001086228 | SCV001452886 | benign | Adrenoleukodystrophy | 2020-09-16 | no assertion criteria provided | clinical testing |